481 related articles for article (PubMed ID: 17069732)
1. [Narcolepsy--new implications of molecular biology].
Knudsen S; Jennum PJ
Ugeskr Laeger; 2006 Oct; 168(43):3699-704. PubMed ID: 17069732
[TBL] [Abstract][Full Text] [Related]
2. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
Nishino S; Kanbayashi T
Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
[TBL] [Abstract][Full Text] [Related]
3. Melanin concentrating hormone in central hypersomnia.
Peyron C; Valentin F; Bayard S; Hanriot L; Bedetti C; Rousset B; Luppi PH; Dauvilliers Y
Sleep Med; 2011 Sep; 12(8):768-72. PubMed ID: 21697009
[TBL] [Abstract][Full Text] [Related]
4. Pediatric narcolepsy.
Peterson PC; Husain AM
Brain Dev; 2008 Nov; 30(10):609-23. PubMed ID: 18375081
[TBL] [Abstract][Full Text] [Related]
5. [Narcolepsy: a new perspective on diagnosis and treatment].
Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
[TBL] [Abstract][Full Text] [Related]
6. [Narcolepsy with cataplexy].
Dauvilliers Y; Arnulf I
Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
[TBL] [Abstract][Full Text] [Related]
7. Relationship between clinical characteristics of narcolepsy and CSF orexin-A levels.
Nakamura M; Kanbayashi T; Sugiura T; Inoue Y
J Sleep Res; 2011 Mar; 20(1 Pt 1):45-9. PubMed ID: 20642748
[TBL] [Abstract][Full Text] [Related]
8. [Neurophysiological examinations in narcolepsy].
Wierzbicka A; Wichniak A; Czasak K; Musińska I; Jakubczyk T; Sek A; Jernajczyk W
Przegl Lek; 2010; 67(9):726-8. PubMed ID: 21387813
[TBL] [Abstract][Full Text] [Related]
9. Narcolepsy and the hypocretins.
Wurtman RJ
Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
[TBL] [Abstract][Full Text] [Related]
10. Hypocretin (orexin) deficiency predicts severe objective excessive daytime sleepiness in narcolepsy with cataplexy.
Baumann CR; Khatami R; Werth E; Bassetti CL
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):402-4. PubMed ID: 16484654
[TBL] [Abstract][Full Text] [Related]
11. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
Overeem S; Scammell TE; Lammers GJ
Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
[TBL] [Abstract][Full Text] [Related]
12. Rapid eye movement sleep behaviour disorder in patients with narcolepsy is associated with hypocretin-1 deficiency.
Knudsen S; Gammeltoft S; Jennum PJ
Brain; 2010 Feb; 133(Pt 2):568-79. PubMed ID: 20129934
[TBL] [Abstract][Full Text] [Related]
13. Hypocretin deficiency in narcolepsy with cataplexy is associated with a normal body core temperature modulation.
Grimaldi D; Agati P; Pierangeli G; Franceschini C; Guaraldi P; Barletta G; Vandi S; Cevoli S; Plazzi G; Montagna P; Cortelli P
Chronobiol Int; 2010 Sep; 27(8):1596-608. PubMed ID: 20854137
[TBL] [Abstract][Full Text] [Related]
14. [Nacrolepsy manifesting initially as cataplexy and sleep paralysis: usefulness of CSF hypocretin-1 examination for early diagnosis].
Kobayashi Y; Miyamoto M; Miyamoto T; Yamazaki K; Hirata K; Kanbayashi T; Shimizu T
Rinsho Shinkeigaku; 2002 Mar; 42(3):233-6. PubMed ID: 12474294
[TBL] [Abstract][Full Text] [Related]
15. Narcolepsy: pathophysiology and pharmacology.
Nishino S
J Clin Psychiatry; 2007; 68 Suppl 13():9-15. PubMed ID: 18078360
[TBL] [Abstract][Full Text] [Related]
16. Narcolepsy: new understanding of irresistible sleep.
Krahn LE; Black JL; Silber MH
Mayo Clin Proc; 2001 Feb; 76(2):185-94. PubMed ID: 11213307
[TBL] [Abstract][Full Text] [Related]
17. Narcolepsy without cataplexy: 2 subtypes based on CSF hypocretin-1/orexin-A findings.
Oka Y; Inoue Y; Kanbayashi T; Kuroda K; Miyamoto M; Miyamoto T; Ikeda A; Shimizu T; Hishikawa Y; Shibasaki H
Sleep; 2006 Nov; 29(11):1439-43. PubMed ID: 17162990
[TBL] [Abstract][Full Text] [Related]
18. Narcolepsy: clinical decision making for the primary care physician.
Khan F; Hazin R; Iqbal M
South Med J; 2009 Dec; 102(12):1246-52. PubMed ID: 20016433
[TBL] [Abstract][Full Text] [Related]
19. Narcolepsy--master of disguise: evidence-based recommendations for management.
Mohsenin V
Postgrad Med; 2009 May; 121(3):99-104. PubMed ID: 19491546
[TBL] [Abstract][Full Text] [Related]
20. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
